We're #hiring a Scientist in Mass Spectrometry! Apply today or share this post with your network: https://t.co/8aoTkuF7sf (ignore what linkedin says - the search is still open) Interested? Please email your CV to: careers@aiproteins.bio

I am incredibly grateful for the opportunity to serve as the CTO at @AI_Proteins . I’m the first person in this role at the company, and it demonstrates our commitment to continue industrializing the process of miniprotein engineering. 🧵

His expertise and leadership are essential as we continue to industrialize our design-build-test process for drug discovery and work to bring #miniprotein medicines to patients across many diseases

James has been a pivotal force in building our protein engineering approach, and as #CTO, he'll be driving the expansion of our core technology platform, integrating #ML, synthetic biology, robotics, and large-scale data analysis to create entirely novel protein therapeutics

Congratulations to Dr. James Bowman @binder_finder_ on his promotion to Chief Technology Officer! https://t.co/SY1MjEBpAV

I am overjoyed to announce that James Bowman @binder_finder_ has been promoted to Chief Technology Officer at @AI_Proteins! 🧵👇

It was an honor to speak from the main stage at @TEDTalks last week about our work at @AI_Proteins

I am so grateful to be back on the TED stage this week in Vancouver to share an update on our story. In the 6 years since my last TED talk, I left academia and founded AI Proteins. I can't wait to tell you about what we've been building. https://t.co/CCbInD6g3S

Welcome Phil Brandish, Chief Development Officer, to the AI Proteins team! https://t.co/Zi2d5uYOk2

Biotechnology firm @AI_Proteins has partnered with the @Mizzou to advance the use of de novo designed miniproteins for targeted radioligand cancer therapy using its AI-powered platform. https://t.co/gSXy4Mlq9p

We're delighted to share that our #Founder Chris Bahl @bahl_lab is now our CEO! https://t.co/kkNKINKIvX

So, I might have ended up on the jumbotron at the Celtics game proudly wearing my @AI_Proteins colors

See Mireia Solà Colom @MireiaSol6, Head of Immunotherapeutics at @AI_Proteins, as she presents our latest progress on the design and optimization of immune cell engagers built from our de novo #miniproteins

and more coverage from Endpoints News @endpts https://t.co/4smGAprCbs

Exciting times at @AI_Proteins! We are getting so close to see our drugs helping patients! https://t.co/zq3UgaHGZh

You can read more about our exciting new collaboration with Bristol Myers Squibb in this coverage from Fierce Biotech https://t.co/uzLqcwR0N7

@AI_Proteins is excited to partner with @bmsnews to develop novel miniprotein-based therapeutics. This collaboration will leverage our cutting-edge AI-driven platform to design and optimize miniproteins with the potential to transform patient outcomes. https://t.co/j7XZAMXveN

We've got some very exciting news to share! https://t.co/GZx4yruDVS and here's a 🧵 about the journey from academia to @AI_Proteins

We're excited that Mireia Solà Colom @MireiaSol6, our Head of Immunotherapeutics will share some of our latest work on immune cell engagers at @ProteinBoston next month!

Our founder, President and CSO Chris Bahl @bahl_lab went to the @Falling_Walls Science Summit last week to explain how we make #miniprotein therapeutics with unprecedented ability to control cellular behavior - you can check out the recording 👇 https://t.co/dQfLcFUraQ